R2 Joins Ant International to Expand Credit Access for SMEs in LATAM
30.10.2025 01:04:00 CET | Business Wire | Press Release
Ant International, a leading global digital payment, digitisation, and financial technology provider, today announced a strategic investment in R2, the leading embedded lending infrastructure company in Latin America (LATAM), to expand access to credit for SMEs across the region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251029918704/en/
From left to right: Roger Larach, Co-Founder and Chief Executive Officer, R2 | Quan Yu, General Manager of Global Credit Services, Ant International | Roger Teran, Co-Founder and Chief Data Officer, R2
R2 enables digital platforms to offer financing solutions quickly and securely through an API-based, end-to-end white-labeled experience. This allows merchants to easily access capital through their existing digital platforms, such as point-of-sale systems, payment processors, marketplaces, and e-commerce solutions. Ant International, a leading fintech player globally, has complementary strengths in inclusive financing through its Global Credit Services unit, which launched SME working capital solutions in Brazil earlier this year. This development marks the latest milestone in Ant International's continued focus on supporting growth in LATAM by working with local partners.
The strategic investment includes a primary capital injection by Ant International, and combines both companies’ unique strengths to advance a shared vision of driving inclusive growth through innovative, trusted digital technologies. R2 will continue to deploy its tested infrastructure, risk and market-tailored credit offerings and local regulatory expertise, while Ant International’s advanced risk capabilities will further enhance R2’s solutions through AI-powered tools and lower the cost of credit. R2’s management team will also continue to lead day-to-day operations, ensuring consistent support for the company’s existing customers and partners, and reaching out to more underserved SMEs in the region.
“Partnering with Ant International is a defining step in R2’s journey,” said Roger Larach, Co-Founder and Chief Executive Officer of R2. “Together, we will combine world-class risk management, AI-driven underwriting, and capital to bring inclusive credit at scale – empowering millions of small and micro businesses while keeping true to our mission of making access to finance frictionless at the point of need.”
R2 was founded in 2020 and operates in Mexico, Chile, Colombia, Peru, and Brazil. The company pioneers its innovative revenue-based financing model through major digital platform partners in the region such as inDrive, Uber Eats, Rappi, Haulmer, and PayU, and has benefitted over 100,000 SMEs in LATAM, where it is estimated that only 13% of SMEs’ demand for credit is currently met by banks and fintechs1. The partnership will also allow R2 to access innovative tech solutions from Ant International's credit services, such as its global credit engine, which helps financial institutions, fintechs, and other qualified lenders make credit decisions with greater efficiency, accuracy, and speed. By improving access to credit for SMEs, R2 and Ant International aim to catalyze economic growth in the region with their shared expertise.
“R2 has been clear in its mission and drive to support SMEs – the backbone of LATAM’s economy – from day one, underpinned by its founders’ deep understanding of the difficulties faced by small businesses, and a strong belief in overcoming these challenges with a digital-first approach,” said Quan Yu, General Manager of Global Credit Services, Ant International. “With this shared commitment to inclusive growth, we are confident that we will be able to accelerate access to opportunities for businesses in the region by turning cutting-edge technologies into real, practical financing solutions.”
About Ant International
With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/
About R2
Founded in 2020 and with operations in Mexico, Chile, Colombia, Peru and Brazil, R2 enables payment processors, POS systems, e-commerce solutions, and marketplaces to provide financing to micro, small and medium businesses in Latin America. Via its APIs, R2 provides an end-to-end lending experience to technology platforms so that they provide capital to users without taking on any risk. R2 works with some of Latin America's leading technology companies including inDrive, Uber Eats, Rappi, Haulmer, and PayU. To learn more, please visit https://r2.co/
1Future Nexus: LatAm SMBs: a 1 trillion financing gap, 29 Apr 2024
View source version on businesswire.com: https://www.businesswire.com/news/home/20251029918704/en/
Contacts
For media enquiries, please contact
Janice Chen, Ant International
janicechen.cyh@ant-intl.com
Alex Goh, Ant International
alex.goh@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom